Nuo Therapeutics, Inc. (AURX)
USD 1.35
(-12.9%)
USD 1.35
(-12.9%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 209.58 Thousand USD | -12.67% |
| 2022 | 240 Thousand USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | -100.0% |
| 2018 | 25.34 Thousand USD | -28.78% |
| 2017 | 35.59 Thousand USD | -52.77% |
| 2016 | 75.35 Thousand USD | -70.38% |
| 2015 | 254.38 Thousand USD | -54.3% |
| 2014 | 556.62 Thousand USD | -49.92% |
| 2013 | 1.11 Million USD | -5.01% |
| 2012 | 1.17 Million USD | 113.46% |
| 2011 | 548.15 Thousand USD | -12.71% |
| 2010 | 627.98 Thousand USD | -100.0% |
| 2009 | 166.73 Billion USD | 448358197.25% |
| 2008 | 37.18 Thousand USD | 244.99% |
| 2007 | 10.77 Thousand USD | 24.66% |
| 2006 | 8647.00 USD | -68.64% |
| 2005 | 27.57 Thousand USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | -100.0% |
| 2000 | 23.76 Thousand USD | 0.0% |
| 1999 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 216.81 Thousand USD | 2.58% |
| 2024 Q1 | 211.37 Thousand USD | 0.85% |
| 2023 Q3 | 209.66 Thousand USD | -7.15% |
| 2023 Q1 | 211.93 Thousand USD | -11.7% |
| 2023 Q2 | 225.8 Thousand USD | 6.55% |
| 2023 FY | 209.58 Thousand USD | -12.67% |
| 2023 Q4 | 209.58 Thousand USD | -0.03% |
| 2022 Q2 | 238.17 Thousand USD | 151.66% |
| 2022 FY | 240 Thousand USD | 0.0% |
| 2022 Q4 | 240 Thousand USD | -9.38% |
| 2022 Q3 | 264.84 Thousand USD | 11.2% |
| 2022 Q1 | 94.64 Thousand USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 Q4 | - USD | -100.0% |
| 2019 FY | - USD | -100.0% |
| 2019 Q1 | 17.31 Thousand USD | -31.71% |
| 2019 Q2 | 10.25 Thousand USD | -40.73% |
| 2019 Q3 | 3083.00 USD | -69.95% |
| 2018 Q1 | 37.19 Thousand USD | 4.52% |
| 2018 Q4 | 25.34 Thousand USD | -25.59% |
| 2018 Q2 | 37.46 Thousand USD | 0.72% |
| 2018 Q3 | 34.06 Thousand USD | -9.07% |
| 2018 FY | 25.34 Thousand USD | -28.78% |
| 2017 Q3 | 64.13 Thousand USD | -28.08% |
| 2017 FY | 35.59 Thousand USD | -52.77% |
| 2017 Q1 | 64.72 Thousand USD | -14.11% |
| 2017 Q2 | 89.17 Thousand USD | 37.79% |
| 2017 Q4 | 35.59 Thousand USD | -44.51% |
| 2016 FY | 75.35 Thousand USD | -70.38% |
| 2016 Q2 | 78.1 Thousand USD | -50.75% |
| 2016 Q4 | 75.35 Thousand USD | 56.26% |
| 2016 Q3 | 48.22 Thousand USD | -38.26% |
| 2016 Q1 | 158.59 Thousand USD | -37.65% |
| 2015 Q2 | 717.08 Thousand USD | -31.42% |
| 2015 FY | 254.38 Thousand USD | -54.3% |
| 2015 Q1 | 1.04 Million USD | 87.85% |
| 2015 Q4 | 254.38 Thousand USD | -57.87% |
| 2015 Q3 | 603.8 Thousand USD | -15.8% |
| 2014 Q2 | 591.62 Thousand USD | -19.12% |
| 2014 Q3 | 544.74 Thousand USD | -7.93% |
| 2014 Q4 | 556.62 Thousand USD | 2.18% |
| 2014 FY | 556.62 Thousand USD | -49.92% |
| 2014 Q1 | 731.53 Thousand USD | -34.19% |
| 2013 Q3 | 1.8 Million USD | 49.07% |
| 2013 Q2 | 1.2 Million USD | 29.38% |
| 2013 FY | 1.11 Million USD | -5.01% |
| 2013 Q4 | 1.11 Million USD | -38.32% |
| 2013 Q1 | 934.24 Thousand USD | -20.16% |
| 2012 FY | 1.17 Million USD | 113.46% |
| 2012 Q2 | 899.19 Thousand USD | 75.68% |
| 2012 Q4 | 1.17 Million USD | 4.25% |
| 2012 Q1 | 511.82 Thousand USD | -6.63% |
| 2012 Q3 | 1.12 Million USD | 24.83% |
| 2011 Q2 | 401.91 Thousand USD | 18.04% |
| 2011 Q4 | 548.15 Thousand USD | 36.19% |
| 2011 FY | 548.15 Thousand USD | -12.71% |
| 2011 Q1 | 340.47 Thousand USD | -45.78% |
| 2011 Q3 | 402.49 Thousand USD | 0.14% |
| 2010 FY | 627.98 Thousand USD | -100.0% |
| 2010 Q1 | 251.12 Thousand USD | -100.0% |
| 2010 Q2 | 1.03 Million USD | 310.3% |
| 2010 Q3 | 779.8 Thousand USD | -24.32% |
| 2010 Q4 | 627.98 Thousand USD | -19.47% |
| 2009 Q4 | 166.73 Billion USD | 56594662.48% |
| 2009 Q1 | 153.37 Thousand USD | 312.44% |
| 2009 FY | 166.73 Billion USD | 448358197.25% |
| 2009 Q3 | 294.6 Thousand USD | 244.25% |
| 2009 Q2 | 85.57 Thousand USD | -44.2% |
| 2008 Q1 | 205.83 Billion USD | 1909620458.49% |
| 2008 Q4 | 37.18 Thousand USD | -100.0% |
| 2008 Q2 | 136.17 Billion USD | -33.85% |
| 2008 FY | 37.18 Thousand USD | 244.99% |
| 2008 Q3 | 280.04 Billion USD | 105.66% |
| 2007 Q2 | 279.51 Billion USD | 159.29% |
| 2007 Q4 | 10.77 Thousand USD | -100.0% |
| 2007 FY | 10.77 Thousand USD | 24.66% |
| 2007 Q1 | 107.8 Billion USD | 1246698176.86% |
| 2007 Q3 | 210.55 Billion USD | -24.67% |
| 2006 Q3 | 234.93 Billion USD | 0.24% |
| 2006 FY | 8647.00 USD | -68.64% |
| 2006 Q1 | 97.93 Billion USD | 355165811.15% |
| 2006 Q2 | 234.37 Billion USD | 139.31% |
| 2006 Q4 | 8647.00 USD | -100.0% |
| 2005 FY | 27.57 Thousand USD | 0.0% |
| 2005 Q3 | 290.35 Thousand USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q4 | 27.57 Thousand USD | -90.5% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2002 Q4 | - USD | -100.0% |
| 2002 Q2 | 8796.00 USD | 0.0% |
| 2002 Q3 | 4140.00 USD | -52.93% |
| 2002 FY | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2001 Q4 | - USD | -100.0% |
| 2001 Q2 | 582.93 Thousand USD | 116.01% |
| 2001 Q3 | 113 Thousand USD | -80.62% |
| 2001 Q1 | 269.86 Thousand USD | 1035.81% |
| 2001 FY | - USD | -100.0% |
| 2000 FY | 23.76 Thousand USD | 0.0% |
| 2000 Q4 | 23.76 Thousand USD | -84.22% |
| 2000 Q3 | 150.56 Thousand USD | 1120.85% |
| 2000 Q2 | 12.33 Thousand USD | -14.94% |
| 2000 Q1 | 14.5 Thousand USD | 0.0% |
| 1999 FY | - USD | 0.0% |